Tackling Therapeutic Resistance in Cancer
More than 229,000 Canadians are newly diagnosed with cancer every year. Cancer is caused by accumulation of genetic alterations, such as mutations, that lead to the uncontrolled proliferation of cells. The Mitogen Activate Protein Kinase (MAPK) pathway is frequently mutated in cancer. The overarching goal of our research is to develop new, and more effective precision medicine strategies for cancers with oncogenic MAPK pathway mutations.
Associated Institutions
The Rose Lab is situated at the Lady Davis Institute of the Jewish General Hospital and affiliated with McGill University in Montreal, QC Canada.
Jewish General Hospital
